Search

Site-specific functional polymers are generally synthesized from functionalized chain transfer agents (CTA) in the presence of catalysts. However, the poor solubility or chemical inertness of CTAs may lead to polymerizations uncontrollable. Now, this issue is addressed by proposing a strategy of designing chain-transfer-catalyst (CTC) that combines catalyst and CTA into one. The occurrence of catalytic effect naturally triggers the chain transfer process to give catalyst-labeled polymers with well-defined structures. As a proof-of-concept, cobalt(III) porphyrin catalysts with one, two and four hydroxyl groups act as efficient CTCs, giving the corresponding site-specific functional poly(propylene carbonate)s (PPC), diversifying the topology of polymers. Furthermore, porphyrin-capped PPCs with controllable Mn in the range of 1,000–16,800 g mol−1 were obtained by using monofunctional CTC (CTCOH). Moreover, different from traditional “catalyst+CTA” systems, a novel dynamic network transfer mechanism of CTCOH was proposed. This study provides a CTC strategy for the synthesis of site-specific functional polymers.

Sleep disturbances exacerbate the progression of Alzheimer's disease (AD), but disturbances of non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep may have different effects. Neurofilament light chain (NfL), an axon-specific protein, is an indicator of the severity of neuronal apoptosis. To investigate whether or not NREM or REM sleep is crucial to neuronal survival, we examined the effects of induced NREM or REM sleep loss on NfL levels in APP/PS1 mice, a model of AD, and their wild-type (WT) C57BL/6 J littermates.At 6 months of age, WT mice and AD mice were equally divided into six groups, namely, the WT-normal sleep (S), WT-total sleep deprivation (TSD), WT-REM deprivation (RD), AD-S, AD-TSD and AD-RD groups, according to the type of sleep intervention applied. All mice underwent 6 days of sleep intervention. Cerebrospinal fluid (CSF) and plasma NfL levels were measured at baseline and on days 2, 4 and 6, and spatial memory was assessed in the Morris water maze (MWM) test.Among the 18 WT and 18 AD mice, CSF and plasma NfL levels were higher in AD-TSD mice than in AD-S or AD-RD mice, while no significant difference was observed between the latter two groups. In AD-TSD mice, CSF and plasma NfL levels increased with the duration of sleep deprivation. A similar pattern of results was observed for the WT groups.NREM sleep loss may increase CSF and plasma NfL levels in both WT and AD mice.

Alpha 1-antichymotrypsin (ACT), an acute-phase protein, has been reported to be increased in the brain and blood of Alzheimer's disease (AD) patients. However, few previous studies have focused on amnestic mild cognitive impairment (aMCI) patients. The aim of our study was to investigate the changing trend in ACT concentrations during the progression of aMCI. Hence, we measured the cerebrospinal fluid (CSF) and serum levels of ACT in aMCI subjects and normal controls (NC) at 2-year follow-up assessments using ELISA and Western blot. Forty-four NCs, 28 stable aMCI (sMCI) patients, and 20 progressive aMCI (pMCI) patients finished the follow-up assessments, and their data were used for analysis. We found that CSF and serum ACT levels of both sMCI and pMCI patients increased over time, while those of NCs remained stable; CSF and serum ACT levels were significantly higher in both sMCI and pMCI patients than in NCs, except for baseline serum ACT. In pMCI patients prior to developing AD, CSF and serum ACT levels were already significantly higher than those in sMCI patients. The ROC curve results demonstrated that combining CSF and serum ACT levels can distinguish aMCI patients from NCs with high specificity and sensitivity. Our data suggest that ACT may be a biomarker for diagnosing aMCI.

Synthesis of polyols from carbon dioxide (CO2) is attractive from the viewpoint of sustainable development of polyurethane industry; it is also interesting to adjust the structure of the CO2-polyols for versatile requirement of polyurethane. However, when renewable malonic acid was used as a starter, the copolymerization reaction of CO2 and propylene oxide (PO) was uncontrollable, since it proceeded slowly (13 h) and produced 40.4 wt% of byproduct propylene carbonate (PC) with a low productivity of 0.34 kg/g. A careful analysis disclosed that the acid value of the copolymerization medium was the key factor for controlling the copolymerization reaction. Therefore, a preactivation approach was developed to dramatically reduce the acid value to ~0.6 mg(KOH)/g by homopolymerization of PO into oligo-ether-diol under the initiation of malonic acid, which ensured the controllable copolymerization, where the copolymerization time could be shortened by 77% from 13 to 3 h, the PC content was reduced by 76% from 40.4 wt% to 9.4 wt%, and the productivity increased by 61% from 0.34 to 0.55 kg/g. Moreover, by means of preactivation approach, the molecular weight as well as the carbonate unit content in the CO2-diol was also controllable.